Cardiovascular disorders
Cardiovascular disorders research articles, Cardiovascular disorders research article, Cardiovascular disorders journals, Cardiovascular disorders journal, Cardiovascular disorders articles, Research on Breast cancer, Cardiovascular disorders
Latest news
- Open access articles published in December
-
- 04/Jan/2010
- November Pubmed visibility statistics
-
- 09/Dec/2009
- Perspectives in Medicinal Chemistry Pubmed visibility statistics
-
- 09/Dec/2009
- Gene Regulation and Systems Biology Pubmed visibility statistics
-
- 09/Dec/2009
- Cancer Informatics Pubmed visibility statistics
-
- 09/Dec/2009
- Biomarker Insights Pubmed visibility statistics
-
- 09/Dec/2009
- Bioinformatics and Biology Insights Pubmed visibility statistics
-
- 09/Dec/2009
- Analytical Chemistry Insights Pubmed visibility statistics
-
- 09/Dec/2009
- Evolutionary Bioinformatics Pubmed visibility statistics
-
- 09/Dec/2009
- 2010 special issues
-
- 07/Dec/2009
- Proposals invited for Translational Oncogenomics special issue
-
- 07/Dec/2009
- Proposals invited for Signal Transduction Insights special issue
-
- 07/Dec/2009
- Proposals invited for Rehabilitation Process and Outcome special issue
-
- 07/Dec/2009
- Proposals invited for Primary Prevention Insights special issue
-
- 07/Dec/2009
- Proposals invited for Perspectives in Medicinal Chemistry special issue
-
- 07/Dec/2009
- Proposals invited for Palliative Care: Research and Treatment special issue
-
- 07/Dec/2009
- Proposals invited for Immunotherapy Insights special issue
-
- 07/Dec/2009
- Proposals invited for Human Parasitic Diseases special issue
-
- 07/Dec/2009
- Proposals invited for Healthy Aging and Clinical Care in the Elderly special issue
-
- 07/Dec/2009
- Proposals invited for Genomics Insights special issue
-
- 07/Dec/2009
- Proposals invited for Genetics and Epigenetics special issue
-
- 07/Dec/2009
- Proposals invited for Environmental Health Insights special issue
-
- 04/Dec/2009
- Proposals invited for Cell and Tissue Transplantation and Therapy special issue
-
- 04/Dec/2009
- Proposals invited for Bone and Tissue Regeneration Insights special issue
-
- 04/Dec/2009
Latest articles
- Efficacy and Safety of Cinacalcet in Chronic Kidney Disease Stage III and IV
- Are Smoking Habits Changing Among Spanish Health Professionals? Results from the SUN Cohort 1999–2008
- Pharmacotherapy Options in Rheumatoid Arthritis: Focus on Tocilizumab, a Recombinant Humanized Anti-Interleukin-6 Receptor Antibody
- Enhanced Expression of Radiation-Induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility
- The Knowledge that Human Tumor Virology can Gain from Studies on Avian Tumor Viruses
- A Pain-Free Lancet with a Small Needle for Glucose Measurement (Provisional PDF)
- Fospropofol Disodium Injection: A Review of its Use as a Sedative-hypnotic Agent for Monitored Anesthesia Care (MAC) Sedation in Adult Patients Undergoing Diagnostic or Therapeutic Procedures
- Hydronephrosis in Infants and Children: Natural History and Risk Factors for Persistence in Children Followed by a Medical Service
- New Tools for a New Job-Single Port Laparoscopic Surgery Equipment
- Domain Organization of Long Autotransporter Signal Sequences
- Using a Matlab Implemented Algorithm for UV-vis Spectral Resolution for pKa Determination and Multicomponent Analysis
- A Novel Approach for Analysis of the Log-Linear Age-Period-Cohort Model: Application to Lung Cancer Incidence
- Insulin Resistance—a Link Between Inflammation and Hepatocarcinogenesis?
- Is Glycogen Synthase Kinase-3β an Ultraconserved Kernel Enzyme?
- Study of Arachidonic Acid Pathway in Human Bladder Tumor
- Neurobiological Pathways Between Chronic Stress and Depression: Dysregulated Adaptive Mechanisms?
- Acute Coronary Syndrome in Pregnancy
- Preliminary Report of a Pilot Tele-Health Palliative Care and Bioethics Program for Residents in Skilled Nursing Facilities
- Global Genetic Profiles of Gene Network Disruption in Bovine Peripheral Blood Mononuclear Cells Induced by Bovine Leukemia Virus (BLV) Infection
- On Message Ribonucleic Acids Targeting to Mitochondria
Most read articles
- Current Status of Monocyte Differentiation-Inducing (MDI) Factors Derived from Human Fetal Membrane Chorion Cells Undergoing Apoptosis after Influenza Virus Infection
- Relationship Between the Plasma Concentration of C-Reactive Protein and Severity of Peripheral Arterial Disease
- Intraspecific ITS Variability in the Kingdom Fungi as Expressed in the International Sequence Databases and Its Implications for Molecular Species Identification
- A Simple Derivation of the Distribution of Pairwise Local Protein Sequence Alignment Scores
- DICOM Structured Reporting and Cancer Clinical Trials Results
- Mammoth and Elephant Phylogenetic Relationships: Mammut Americanum, the Missing Outgroup
- Evaluation of Two Outlier-Detection-Based Methods for Detecting Tissue-Selective Genes from Microarray Data
- Systems Biology-Based Identification of Crosstalk between E2F Transcription Factors and the Fanconi Anemia Pathway
- Exploring the Evolutionary History of the Differentially Expressed Genes between Human Populations: Action of Recent Positive Selection
- On the Adaptive Design Rules of Biochemical Networks in Evolution
- Fast Genes and Slow Clades: Comparative Rates of Molecular Evolution in Mammals
- Phylogenetic diversity (PD) and biodiversity conservation: some bioinformatics challenges
- Identification and Quantitation of Asparagine and Citrulline Using High-Performance Liquid Chromatography (HPLC)
- In Silico Promoter Analysis can Predict Genes of Functional Relevance in Cell Proliferation: Validation in a Colon Cancer Model
- Identification of Conflicting Selective Effects on Highly Expressed Genes
(previous 30 days)Site updates
Journal: Clinical Medicine Insights: Cardiology
Journal: Clinical Medicine Insights: Case Reports
Acute Coronary Syndrome in Pregnancy (08/Dec/2009)
Acute coronary syndrome (ACS) in pregnancy has traditionally been considered to be a rare event, but the combination of normal physiological changes of pregnancy and more prevalent cardiovascular risk factors are increasing its incidence in this population. The present report describes a 39 year-old woman that is seven weeks pregnant...
Osler-Weber-Rendu (OWR) Disease and Heart Failure (25/Nov/2009)
OWR is a genetic disease, transmitted as an autosomal dominant disorder characterized by arteriovenous malformations pre-dominantly involving the mucocutaneous epithelium. One of the significant complications is the development of arteriovenous fistulas in different organs like the liver and brain. One of the rarest complications of this arteriovenous conduit is a...
Doty’s Method (Two Sinus Reconstructions) of Supravalvular Aortic Stenosis in Williams’s Syndrome (24/Nov/2009)
We experienced a successful surgical Williams’s syndrome case of extended aortoplasty by means of Doty’s method (two sinus reconstructions) for congenital supravalvular aortic stenosis. Case was 29-year-old woman, who had no complaint except heart murmur and dyspnea. The retrograde aortography and Digital Subtraction Angiography (DSA) demonstrated localized stenosis just above...
Safety and Efficacy of Ivabradine in the Management of Stable Angina Pectoris (24/Nov/2009)
The first selective If current inhibitor, ivabradine, lowers heart rate (HR) at rest and during exercise with no vasomotor, negative inotropic, or negative lusitropic effects. Given that elevated resting HR is a key factor in the onset of myocardial ischemia and a strong independent predictor of cardiovascular outcomes, ivabradine provides new therapeutic prospects in coronary artery disease (CAD). Its selective HR-lowering action has proven anti-ischemic and anti-anginal efficacy, and ivabradine is currently indicated for the...
Effects of Nebivolol on Endothelial Function and Exercise Parameters in Patients with Slow Coronary Flow (03/Nov/2009)
Objective: Earlier studies have reported that a decrease in exercise capacity might indicate endothelial dysfunction. However, the effects of improvement of endothelial functions on exercise capacity have not been evaluated. The aim of the present study is to investigate the effects of nebivolol on flow-mediated dilatation (FMD), and on the...
The Impact of Obesity on Adverse Cardiovascular Outcomes in the General Population and in Patients with Type 2 Diabetes (28/Oct/2009)
Objectives: There is an established causal link between obesity and cardiovascular outcomes. The aim of this review was to determine whether an independent relationship exists between anthropometric measurements of weight (typically body mass index [BMI]) and cardiovascular outcomes (e.g. angina, myocardial infarction, congestive heart failure, stroke, and mortality due to...
Fixed-dose Combination Therapy in Hypertension: Focus on Fixed-dose Combination of Amlodipine and Valsartan (Exforge®) (19/Oct/2009)
Hypertension is the leading cause of disability and cardiovascular mortality world-wide. Approximately one-third of the US adult population and over a billion people world-wide have hypertension. Despite increased awareness of hypertension and availability of many effective antihypertensive agents, only one third of patients achieve their target blood pressure (BP). All...
Pitavastatin in the Management of Hypercholesterolemia (13/Oct/2009)
Pitavastatin is an HMG-CoA reductase inhibitor that significantly reduces the plasma levels of total cholesterol, LDL-C and triglycerides, while also causing modest elevation of the plasma high-density cholesterol (HDL-C) level. This statin is minimally metabolized by the cytochrome P-450 (CYP) isozymes; it is glucuronized and converted to the inactive lactone...
Left Ventricular Rupture Post Mitral Valve Replacement (23/Sep/2009)
Prevention is better than cure best applies here. As per many authors, posterior leaflet chordae preservation prevent Left ventricular rupture (LVR) and preserve LV geometry. We are presenting here 5 types of left ventricular rupture (LVR) post Mitral valve replacement (MVR) with different methods to repair with the advantages and...
Good News from Aliskiren? (17/Sep/2009)
The renin-angiotensin system can be inhibited through inhibition of angiotensin I generation from angiotensinogen by direct renin inhibitors, inhibition of angiotensin II generation from angiotensin I by angiotensin-converting enzyme inhibitors and by direct inhibition of the action of angiotensin II receptor level. Aliskiren, the first direct renin inhibitor to reach...
Stress Cardiomyopathy (Takotsubo Cardiomyopathy) (17/Sep/2009)
Background: Due to the rise in the number of reports of stress cardiomyopathy in the literature, awareness of this condition is increasing. Although different names have been used to describe this condition, the similarities in clinical, electrocardiographic, echocardiographic, and angiographic features suggest that they represent the same spectrum of diseases...
Aliskiren for the Treatment of Hypertension: An Update (15/Sep/2009)
Hypertension can lead to significant morbidity and mortality, and requires lifestyle modifications with or without drug therapy to achieve target blood pressure control. Various classes of anti-hypertensive medications are available to healthcare providers. Choice of medications is based not only on efficacy but also tolerability and cost. Aliskiren is the...
Aspirin and clopidogrel are the most commonly used antiplatelet agents in patients with coronary artery disease. The existence of resistance to these agents has been a controversial issue and new drugs are being developed to overcome this problem. Laboratory tests, which can identify resistance and correlate this with clinical outcome,...
Reduction in Risk of Myocardial Infarction, Stroke, and Death from Cardiovascular Causes. Focus on Rampiril (31/Aug/2009)
Several clinical studies demonstrate a beneficial role of angiotensin-converting enzyme (ACE) inhibitors in patients with myocardial infarction, hypertension and diabetes mellitus. This review focuses on the effects of ramipril, a weak inhibitor of ACE that is rapidly hydrolyzed to ramiprilat, an active metabolite. The Heart Outcome Prevention Evaluation (HOPE) study...
Once used only as third-line therapy in the management of chronic pain states, methadone is now being used as first- and second-line therapy. Most risks and the stigma associated with methadone use have been known for years. Only over the past decade or so have the unique pharmacokinetic-pharmacodynamic properties and...
Suppression of the Renin-Angiotensin-Aldosterone system (RAAS) is an established intervention in the management of cardiovascular disease. Large, randomized controlled trials have provided a sound evidence base for the use of mineralocorticoid receptor antagonists to block the end product of the RAAS in the treatment of heart failure. However, the place...
Clopidogrel Bisulfate: A Review of its Use in the Management of Acute Coronary Syndrome (07/Aug/2009)
Antiplatelet therapy is the cornerstone in the modern therapy of patients with acute coronary syndromes (ACS), because of the unique role of platelets in coronary thrombosis. Clopidogrel in combination with aspirin is the current “gold standard” for reducing cardiovascular events in such patients, providing a synergistic platelet inhibition through different...
Chronic stable angina pectoris results from a fixed coronary arterial obstruction causing an imbalance between myocardial oxygen supply and demand. Current therapy aims to reduce cardiovascular events (vasculoprotective) thereby improving survival, and/or relieve ischemic symptoms (antianginal) thereby improving the quality of life. Vasculoprotective therapy consists of lifestyle modification, antiplatelet agents,...
Safety and Efficacy of the bi-Sulfydryl ACE-Inhibitor Zofenopril in the Management of Cardiovascular Disease (15/Jul/2009)
In the 1970s, pharmacological therapy interrupting the renin-angiotensin system was considered beneficial for patients with high-renin hypertension. Angiotensin-converting enzyme (ACE) inhibitors proved to be effective not only in patients with high renin and elevated blood pressure, but also in many hypertensive patients with normal levels of plasma renin activity. ACE...
Introductory Editorial (09/Jul/2009)
Garry Walsh Reader in Inflammation and Immunity, University of Aberdeen Scotland, United Kingdom.
Introductory Editorial (09/Jul/2009)
Garry Walsh Reader in Inflammation and Immunity, University of Aberdeen Scotland, United Kingdom.
Hypertension is one of the most important modifiable risk factor for cardiovascular morbidity and mortality and is highly prevalent. Recent guidelines and advisory statements have recommended lower thresholds and goals for patients with hypertension. However, approximately two-thirds of hypertensive patients do not achieve the goals. Poor adherence to anti-hypertensive medication...
HMGCoA-Reductase Inhibitors in Dementia: Benefit or Harm (12/Jun/2009)
Dementia is a syndrome characterized by a decline in cognitive function. Alzheimer’s disease and cerebro-vascular disease are the most common causes of dementia. Many factors (genetic, life style, vascular etc.) appear to play some role in the development of dementia. Statins significantly reduce vascular disease and could reduce cognitive impairment...
Assessment of Myocardial Scar; Comparison Between 18F-FDG PET, CMR and 99Tc-Sestamibi (08/Jun/2009)
Objective: Patients with heart failure and ischaemic heart disease may obtain benefit from revascularisation if viable dysfunctional myocardium is present. Such patients have an increased operative risk, so it is important to ensure that viability is correctly identified. In this study, we have compared the utility of 3 imaging modalities to detect myocardial scar. Design: Prospective, descriptive study. Setting: Tertiary cardiac centre. Patients: 35 patients (29 male, average age 70 years) with coronary artery disease and symptoms of...
Excessive sleepiness (ES) is responsible for significant morbidity and mortality due to its association with cardiovascular disease, cognitive impairment, and occupational and transport accidents. ES is also detrimental to patients’ quality of life, as it affects work and academic performance, social interactions, and personal relationships. Armodafinil is the R-enantiomer of...
Background: Bone-marrow derived progenitor cells (PCs) may play a role in maintaining vascular health by actively repairing damaged endothelium. The purpose of this study in asymptomatic Old Order Amish men (n = 90) without hyper- tension or diabetes was to determine if PC count, as determined by CD34+ cell count...
Pathway Analysis of Differentially Expressed Genes in Patients with Acute Aortic Dissection (06/May/2009)
Background: Acute aortic dissection (AAD) is a life-threatening condition with high mortality and a relatively unclarified pathophysiological mechanism. Although differentially expressed genes in AAD have been recognized, interactions between these genes remain poorly defined. This study was conducted to gain a better understanding of the molecular mechanisms underlying AAD and...
Toshio Imanishi, Hiroto Tsujioka and Takashi AkasakaDepartment of Cardiovascular Medicine, Wakayama Medical University. 811-1, Kimiidera, Wakayama City, Wakayama, Japan.AbstractThe renin-angiotensin system (RAS) activity is a key factor in the pathophysiology and development of hypertension, atherosclerosis, heart failure, and renal disease. It is unclear whether angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers...
Efficacy and safety of fixed-dose Lercanidipine-Enalapril for the treatment of hypertension (20/Apr/2009)
Christos Chatzikyrkou, Hermann Haller and Jan MenneDepartment of Nephrology, Hannover Medical School, Germany.AbstractHypertension is the most important preventable cause of premature death in the developed countries, and the benefits of antihypertensive drugs regarding cardiovascular morbidity and mortality are well established. Nevertheless, adequate control is achieved only in the minority of...
Improvement of Young and Elderly Patient’s Knowledge of Heart Failure After an Educational Session (20/Apr/2009)
Jérôme Roncalli1,2, Laurence Perez1, Atul Pathak1,3, Laure Spinazze1, Sandrine Mazon1, Olivier Lairez1, Daniel Curnier2, Joëlle Fourcade1, Meyer Elbaz1, Didier Carrié1, Jacques Puel1,4, Jean-Marie Fauvel1 and Michel Galinier1,21Rangueil University Hospital, Department of Cardiology and Heart Failure Educational Centre (Centre d’ Education pour Patient Insuffisant Cardiaque (CEPIC)), Toulouse, France. 2INSERM U858-I2MR, Hôpital...